A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer.
A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer. Ann Oncol. 2004 Jun; 15(6):928-32.